• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature . SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis

tetano

Editor, Senior Moderator
Nature


. 2021 May 12.
doi: 10.1038/s41586-021-03610-3. Online ahead of print.
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis


Yaara Finkel[SUP] #[/SUP][SUP] 1 [/SUP], Avi Gluck[SUP] #[/SUP][SUP] 1 [/SUP], Aharon Nachshon[SUP] #[/SUP][SUP] 1 [/SUP], Roni Winkler[SUP] 1 [/SUP], Tal Fisher[SUP] 1 [/SUP], Batsheva Rozman[SUP] 1 [/SUP], Orel Mizrahi[SUP] 1 [/SUP], Yoav Lubelsky[SUP] 2 [/SUP], Binyamin Zuckerman[SUP] 2 [/SUP], Boris Slobodin[SUP] 3 [/SUP], Yfat Yahalom-Ronen[SUP] 4 [/SUP], Hadas Tamir[SUP] 4 [/SUP], Igor Ulitsky[SUP] 2 [/SUP], Tomer Israely[SUP] 4 [/SUP], Nir Paran[SUP] 4 [/SUP], Michal Schwartz[SUP] 5 [/SUP], Noam Stern-Ginossar[SUP] 6 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing coronavirus disease 19 pandemic[SUP]1[/SUP]. Coronaviruses developed varied mechanisms to repress host mRNA translation to allow the translation of viral mRNAs and concomitantly block the cellular innate immune response[SUP]2,3[/SUP]. Although different SARS-CoV-2 proteins are implicated in host expression shutoff[SUP]4-7[/SUP], a comprehensive picture of the effects of SARS-CoV-2 infection on cellular gene expression is lacking. Here, we combine RNA-sequencing, ribosome profiling and metabolic labeling of newly synthesized RNA, to comprehensively define the mechanisms that are utilized by SARS-CoV-2 to shutoff cellular protein synthesis. We show that infection leads to a global reduction in translation, but viral transcripts are not preferentially translated. Instead, we find that infection leads to accelerated degradation of cytosolic cellular mRNAs which facilitates viral takeover of the mRNA pool in infected cells. Moreover, we reveal that the translation of transcripts whose expression is induced in response to infection, including innate immune genes, is impaired. We demonstrate this impairment is likely mediated by inhibition of nuclear mRNA export, preventing newly transcribed cellular mRNAs from accessing ribosomes. Overall, our results uncover the multipronged strategy employed by SARS-CoV-2 to commandeer the translation machinery and to suppress host defenses.
 
Back
Top Bottom